TUCSON, AZ – March 25, 2013 – Azbil BioVigilant, Inc., (www.biovigilant.com), inventors of Instantaneous Microbial Detection™, announced today that the U.S. Patent and Trademark Office (USPTO) has issued a decision rejecting TSI’s latest arguments in the reexamination of U.S. Patent No. 6,831,279. Specifically, on March 19, 2013, the USPTO found that all claims of TSI’s patent are unpatentable. The TSI patent is also the basis for TSI’s patent infringement lawsuit against Azbil BioVigilant. TSI failed in a prior litigation filed in Minnesota against Azbil BioVigilant on the same patent, voluntarily dismissing the action.
Representing Azbil BioVigilant in its patent litigation is Amster, Rothstein & Ebenstein LLP.
With headquarters in Tucson, Arizona, Azbil BioVigilant invented instantaneous microbial detection technology to address environmental monitoring needs in the pharmaceutical, biotechnology, healthcare, and environmental applications. Azbil BioVigilant’s IMD systems detect – instantaneously and in real-time – particle count, size, and biological status. Unlike other rapid microbial methods, Azbil BioVigilant’s optically-based systems require no staining, no reagents, no waiting period, and little human intervention. The company holds 19 patents with an additional 37 applications pending. Azbil BioVigilant’s parent company is Azbil Corporation of the Azbil Group, part of the TOPIX Mid400 traded on the Tokyo Stock Exchange. For more information, go to www.biovigilant.com.
The Azbil Group consists of Azbil Corporation and its affiliate and subsidiary companies. The Azbil Group has operations in 18 countries worldwide and more than 9,500 employees. For detailed information, visit www.azbil.com.
IMD-A®, IMD-W™, BioVigilant®, the BioVigilant logo, and the term Instantaneous Microbial Detection™ are the trademarks or registered trademarks of Azbil BioVigilant, Inc. in the United States and/or other countries. Other names or brands may be the property of others.